Andreas Schlosser

Dr. Andreas Schlosser


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
BABikash Adhikari
Bikash Adhikari
JBJelena Bozilovic
Jelena Bozilovic
MDMathias Diebold
Mathias Diebold
JSJessica Denise Schwarz
Jessica Denise Schwarz
JHJulia Hofstetter
Julia Hofstetter
Elmar WolfElmar Wolf
Elmar Wolf

1 August 2020 in Cancer Immunology Research
Verified
Journal Article
Closed access
PDF file
FEFlorian Erhard
Florian Erhard
LDLars Dölken
Lars Dölken
BSBastian Schilling
Bastian Schilling
ASAndreas Schlosser
Andreas Schlosser
The success of cancer immunotherapy relies on the ability of cytotoxic T cells to specifically recognize and eliminate tumor cells based on peptides presented by HLA-I. Although the peptide epitopes that elicit the corresponding immune response often remain unidentified, it is generally assumed that neoantigens, due to tumor-specific mutations, are the most common targets. Here, we used a mass spectrometric approach to show an underappreciated class of epitopes that accounts for up to 15% of HLA-I peptides for certain HLA alleles in various tumors and patients. These peptides are translated from cryptic open reading frames in supposedly noncoding regions in the genome and are mostly unidentifiable with conventional computational analyses of mass spectrometry (MS) data. Our approach, Peptide-PRISM, identified thousands of such cryptic peptides in tumor immunopeptidomes. About 20% of these HLA-I peptides represented the C-terminus of the corresponding translation product, suggesting frequent proteasome-independent processing. Our data also revealed HLA-I allele–dependent presentation of cryptic peptides, with HLA-A*03 and HLA-A*11 presenting the highest percentage of cryptic peptides. Our analyses refute the reported frequent presentation of HLA peptides generated by proteasome-catalyzed peptide splicing. Thus, Peptide-PRISM represents an important step toward comprehensive identification of HLA-I immunopeptidomes and reveals cryptic peptides as an abundant class of epitopes with potential relevance for novel immunotherapeutic approaches.

30 March 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JHJens Hör
Jens Hör
GGGeneviève Garriss
Geneviève Garriss
SGSilvia Di Giorgio
Silvia Di Giorgio
LHLisa‐Marie Hack
Lisa‐Marie Hack
JVJens T Vanselow
Jens T Vanselow
JVJörg Vogel
Jörg Vogel
RNA–protein interactions are the crucial basis for many steps of bacterial gene expression, including post‐transcriptional control by small regulatory RNAs (sRNAs). In stark contrast to recent progress in the analysis of Gram‐negative bacteria, knowledge about RNA–protein complexes in Gram‐positive species remains scarce. Here, we used the Grad‐seq approach to draft a comprehensive landscape of such complexes in Streptococcus pneumoniae , in total determining the sedimentation profiles of ~ 88% of the transcripts and ~ 62% of the proteins of this important human pathogen. Analysis of in‐gradient distributions and subsequent tag‐based protein capture identified interactions of the exoribonuclease Cbf1/YhaM with sRNAs that control bacterial competence for DNA uptake. Unexpectedly, the nucleolytic activity of Cbf1 stabilizes these sRNAs, thereby promoting their function as repressors of competence. Overall, these results provide the first RNA/protein complexome resource of a Gram‐positive species and illustrate how this can be utilized to identify new molecular factors with functions in RNA‐based regulation of virulence‐relevant pathways.

1 April 2020 in ImmunoHorizons
Verified
Journal Article
Open access
PDF file
PSPhilipp Schreiner
Philipp Schreiner
THThomas Harrer
Thomas Harrer
CSCarmen Scheibenbogen
Carmen Scheibenbogen
SLStephanie Lamer
Stephanie Lamer
ASAndreas Schlosser
Andreas Schlosser
BPBhupesh K. Prusty
Bhupesh K. Prusty
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a multifactorial disorder with many possible triggers. Human herpesvirus (HHV)–6 and HHV-7 are two infectious triggers for which evidence has been growing. To understand possible causative role of HHV-6 in ME/CFS, metabolic and antiviral phenotypes of U2-OS cells were studied with and without chromosomally integrated HHV-6 and with or without virus reactivation using the histone deacetylase inhibitor trichostatin-A. Proteomic analysis was conducted by pulsed stable isotope labeling by amino acids in cell culture analysis. Antiviral properties that were induced by HHV-6 transactivation were studied in virus-naive A549 cells challenged by infection with influenza-A (H1N1) or HSV-1. Mitochondria were fragmented and 1-carbon metabolism, dUTPase, and thymidylate synthase were strongly induced by HHV-6 reactivation, whereas superoxide dismutase 2 and proteins required for mitochondrial oxidation of fatty acid, amino acid, and glucose metabolism, including pyruvate dehydrogenase, were strongly inhibited. Adoptive transfer of U2-OS cell supernatants after reactivation of HHV-6A led to an antiviral state in A549 cells that prevented superinfection with influenza-A and HSV-1. Adoptive transfer of serum from 10 patients with ME/CFS produced a similar fragmentation of mitochondria and the associated antiviral state in the A549 cell assay. In conclusion, HHV-6 reactivation in ME/CFS patients activates a multisystem, proinflammatory, cell danger response that protects against certain RNA and DNA virus infections but comes at the cost of mitochondrial fragmentation and severely compromised energy metabolism.

7 February 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
MLMaria Lozano-Rabella
Maria Lozano-Rabella
AGAndrea Garcia-Garijo
Andrea Garcia-Garijo
JPJara Palomero
Jara Palomero
AYAnna Yuste-Estevanez
Anna Yuste-Estevanez
FEFlorian Erhard
Florian Erhard
AGAlena Gros
Alena Gros
Purpose: Tumor antigens are central to antitumor immunity. Recent evidence suggests that peptides from noncanonical (nonC) aberrantly translated proteins can be presented on HLA-I by tumor cells. Here, we investigated the immunogenicity of nonC tumor HLA-I ligands (nonC-TL) to better understand their contribution to cancer immunosurveillance and their therapeutic applicability. Experimental Design: Peptides presented on HLA-I were identified in 9 patient-derived tumor cell lines from melanoma, gynecologic, and head and neck cancer through proteogenomics. A total of 507 candidate tumor antigens, including nonC-TL, neoantigens, cancer-germline, or melanocyte differentiation antigens, were tested for T-cell recognition of preexisting responses in patients with cancer. Donor peripheral blood lymphocytes (PBL) were in vitro sensitized against 170 selected nonC-TL to isolate antigen-specific T-cell receptors (TCR) and evaluate their therapeutic potential. Results: We found no recognition of the 507 nonC-TL tested by autologous ex vivo expanded tumor-reactive T-cell cultures while the same cultures demonstrated reactivity to mutated, cancer-germline, or melanocyte differentiation antigens. However, in vitro sensitization of donor PBL against 170 selected nonC-TL, led to the identification of TCRs specific to three nonC-TL, two of which mapped to the 5′ UTR regions of HOXC13 and ZKSCAN1, and one mapping to a noncoding spliced variant of C5orf22C. T cells targeting these nonC-TL recognized cancer cell lines naturally presenting their corresponding antigens. Expression of the three immunogenic nonC-TL was shared across tumor types and barely or not detected in normal cells. Conclusions: Our findings predict a limited contribution of nonC-TL to cancer immunosurveillance but demonstrate they may be attractive novel targets for widely applicable immunotherapies. See related commentary by Fox et al., p. 2173

31 January 2019 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
YLYing H Li
Ying H Li
XLXianhui Liu
Xianhui Liu
JVJens T Vanselow
Jens T Vanselow
HZHaiyan Zheng
Haiyan Zheng
ASAndreas Schlosser
Andreas Schlosser
JCJoanna C Chiu
Joanna C Chiu
Circadian clocks coordinate time-of-day-specific metabolic and physiological processes to maximize organismal performance and fitness. In addition to light and temperature, which are regarded as strong zeitgebers for circadian clock entrainment, metabolic input has now emerged as an important signal for clock entrainment and modulation. Circadian clock proteins have been identified to be substrates of O-GlcNAcylation, a nutrient sensitive post-translational modification (PTM), and the interplay between clock protein O-GlcNAcylation and other PTMs is now recognized as an important mechanism by which metabolic input regulates circadian physiology. To better understand the role of O-GlcNAcylation in modulating clock protein function within the molecular oscillator, we used mass spectrometry proteomics to identify O-GlcNAcylation sites of PERIOD (PER), a repressor of the circadian transcriptome and a critical biochemical timer of the Drosophila clock. In vivo functional characterization of PER O-GlcNAcylation sites indicates that O-GlcNAcylation at PER(S942) reduces interactions between PER and CLOCK (CLK), the key transcriptional activator of clock-controlled genes. Since we observe a correlation between clock-controlled daytime feeding activity and higher level of PER O-GlcNAcylation, we propose that PER(S942) O-GlcNAcylation during the day functions to prevent premature initiation of circadian repression phase. This is consistent with the period-shortening behavioral phenotype of per(S942A) flies. Taken together, our results support that clock-controlled feeding activity provides metabolic signals to reinforce light entrainment to regulate circadian physiology at the post-translational level. The interplay between O-GlcNAcylation and other PTMs to regulate circadian physiology is expected to be complex and extensive, and reach far beyond the molecular oscillator. Circadian clocks are self-sustained, endogenous pacemakers that enable organisms to anticipate daily environmental changes and resource abundance to perform specific time-of-day activities and achieve optimal survival. Multiple time cues are interpreted by circadian clocks to facilitate synchrony between organisms and their environment. A large body of work have identified light and temperature as important zeitgebers. More recent works highlight the significance of metabolic cues as signals to entrain and modulate circadian clocks to drive proper rhythms of physiology and behavior. Metabolic input, primarily through clock-controlled feeding activity, can regulate circadian physiology through multiple pathways. Some of these pathways are unknown while others, such as the O-GlcNAcylation of clock proteins, are just emerging. In this study, we utilized mass spectrometry proteomics to identify O-GlcNAcylation sites of the Drosophila PERIOD (PER) protein, a key regulator of the clock, and performed site-specific functional characterization of PER O-GlcNAcylation. Our results support that PER(Ser942) O-GlcNAcylation, a nutrient-sensitive protein modification that is expected to be more abundant during feeding period, prevents newly synthesized PER from prematurely performing its function during daytime and therefore restricts its activity to nighttime when flies are fasting. This study provides new insights into the mechanisms linking nutrient input and circadian physiology.